Printer Friendly

BIOCHIPS MARKET EXPECTED TO REACH $3.840.7 MILLION BY 20013.

According to a new technical market research report, Biochip Markets: Microarrays and Lab-on-a-Chip (BIO049B) from BCC Research (www.bccresearch.com), the world market for biochip products will be worth some 1,937.9 million in 2007, a figure that is expected to increase to $2115.6 million in 2008 and $3,840.7 million in 2013, a compound annual growth rate (CAGR) of 12.7%.

The market is broken down into applications of DNA microarrays, protein microarrays, emerging microarrays and lab-on-a-chip (LOAC) technologies. Of these sectors, DNA microarrays have the largest share of the market, worth an estimated $947.3 million in 2007 and expected to reach $999 million in 2007 and $1,644.2 million by 2013, a CAGR of 10.8%. The overall growth rate of DNA microarrays is slowed by the continuing maturation of the gene expression market, which represents a large segment of DNA microarrays. However, newer applications for DNA microarrays are emerging, including SNP genotyping, and are providing a significant growth impetus to this market segment. LOACs have the second largest market share, expected to reach nearly $691.3 million in 2008 and $1,245.4 million by 2013, a CAGR of 12.5%. DNA microarrays and LOACs are projected to continue to dominate the biochip market through 2013.

Protein microarrays are an emerging market opportunity as a result of continuing advances in proteomics to understand gene function and diseases. Tissue microarrays represent a growth opportunity in the emerging microarray segment.

Report published September 2007 at a print price of $4250 by BCC Research (www.bccresearch.com), 40 Washington Street, Suite 110, Wellesley, MA; Telephone: 866/285-7215,
COPYRIGHT 2008 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Equipment Update
Date:Jan 1, 2008
Words:272
Previous Article:DATASCOPE AIMS TO CREATE GROWTH MARKET IN PATIENT MONITORING.
Next Article:AETHLON FILES PATENT ON HEMOPURIFIER USE FOR BIOMARKERS.
Topics:


Related Articles
US BIOCHIP PRODUCTS & SERVICES TO GROW 43% ANNUALLY THROUGH THE YEAR 2004.
Roche Diagnostics and CombiMatrix Sign Agreement.
Eppendorf enters microarray market. (Executive briefing: news, trends & market intelligence for instrument executives).
Tegal sells 900 Series etch system for biochip fab to Zyomyx.
Study: ten most attractive markets for MEMS/MST devices.
QIAGEN acquires two mass spec sample prep companies.
Endpoint: manufacturing.
Peace Corps seeks enviros.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters